Detalles de la búsqueda
1.
Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-Infected adults treated with rilpivirine or Efavirenz for 96 weeks in the ECHO and THRIVE trials.
Clin Infect Dis;
59(3): 425-34, 2014 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24729492
2.
Safety, Pharmacokinetics, and Pharmacodynamics of the ADAMTS-5 Inhibitor GLPG1972/S201086 in Healthy Volunteers and Participants With Osteoarthritis of the Knee or Hip.
Clin Pharmacol Drug Dev;
11(1): 112-122, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34859612
3.
The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086/GLPG1972 in knee osteoarthritis.
Osteoarthr Cartil Open;
3(4): 100209, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36474770
4.
Comparative Efficacy, Safety and Immunogenicity of Hepavax-Gene TF and Engerix-B Recombinant Hepatitis B Vaccines in Neonates in China.
Pediatr Infect Dis J;
36(1): 94-101, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27753794
5.
Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study.
Vaccine;
35(10): 1448-1454, 2017 03 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28190741
6.
Lipid metabolism and lipodystrophy in HIV-1-infected patients: the role played by nonnucleoside reverse transcriptase inhibitors.
AIDS Rev;
17(1): 21-36, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25472015
7.
Vitamin D deficiency in HIV: a shadow on long-term management?
AIDS Rev;
16(2): 59-74, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24759452
8.
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).
Antivir Ther;
19(2): 191-200, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24430534
Resultados
1 -
8
de 8
1
Próxima >
>>